Making Genetics advances in genetics and epigenetics. The Spanish biotech company seeks $3.6 million (€3 million) to conduct a clinical trial in Europe. Making Genetics specializes...
Centrexion Therapeutics will allot the funding to the next phase of its CNTX-4975 drug.